Risteys ·

Coding

Definition

OMOP Concept ID: 3004560— open in OHDSI Athena.
Part of collection: Lymphocytes with 2 other OMOP concepts — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3004560	li-lymfosy	— (—)	42	46	100.00%	Distribution not available

Cohort

Number of people: 43 (51.16% female)

Year of birth distribution

No data available for the year of birth distribution.

Age at first measurement

Age at last measurement

Age at start of registry

No data available for the age at start of registry distribution.

Duration from first to last measurement

No data available for the duration from to last measurement distribution.

Statistics

People with ≥2 records: 9.30%
Median number of measurements per person: 1.0
Median duration from first to last measurement: —

Number of measurements over the years

Number of measurements per person

No data available for the distribution of number of measurements per person.

Distribution of lab values

No data available for the lab value distribution.

Reference range

N people

N records

—

Value range per person

No data available for the distribution of value range per person.

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other symptoms and signs involving the nervous and musculoskeletal systems

18.19

13.33

1.2

1.0

—

Fitting and adjustment of other devices

16.15

7.07

1.1

1.0

—

Mouth breathing

9.22

6.27

1.1

—

Special screening examination for other diseases and disorders

+∞

6.25

1.2

0.0

—

Asthma, unspecified (mode)

8.42

3.46

1.1

1.2

—

Asthma, unspecified (mode), excluding more controls

8.34

3.44

1.1

1.2

—

Persons encountering health services for specific procedures and health care

3.18

3.27

1.1

—

Asthma (mode)

5.25

3.08

1.1

1.2

—

Diagnoses used for exclusion with ILD

10.00

2.98

1.0

—

Open wound of wrist and hand

4.14

2.89

1.0

—

Symptoms and signs involving the digestive system and abdomen

3.54

2.85

1.0

1.1

—

Asthma

4.58

2.53

1.1

1.2

—

Asthma, excluding more controls

4.56

2.52

1.1

1.2

—

Impingement syndrome of shoulder

6.25

2.37

1.2

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

6.25

2.37

1.2

1.1

—

Tonsillectomy and adenotomy

3.48

2.36

1.0

1.1

—

Other dorsopathies, not elsewhere classified

3.01

2.28

1.0

1.1

—

Dorsopathies

2.93

2.21

1.0

1.1

—

Other headache syndromes

4.98

2.06

1.2

1.0

—

Abdominal and pelvic pain

2.95

2.06

1.0

1.1

—

COPD differential diagnosis

3.90

2.00

1.1

1.2

—

ILD differential diagnosis

3.90

2.00

1.1

1.2

—

Excluding asthma or asthma-COPD overlap

3.90

2.00

1.1

1.2

—

Other pulmonary diagnosis

3.90

2.00

1.1

1.2

—

Migraine

3.89

1.92

1.0

1.1

—

Chronic diseases of tonsils and adenoids

2.84

1.89

1.0

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.61

1.86

1.0

1.1

—

Appendectomy

2.82

1.82

1.1

—

Spondylosis

3.61

1.81

1.0

1.2

—

Chronic periodontitis, complicated

3.44

1.79

1.2

1.1

—

ILD medications: immunosuppressive drugs

3.02

1.76

1.0

1.1

—

Asthma (only as main-diagnosis)

3.73

1.75

1.2

—

Asthma (only as main-diagnosis), excluding more controls

3.68

1.73

1.2

—

Obesity related asthma

3.85

1.71

1.0

—

Chronic sinusitis

3.84

1.71

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

2.95

1.68

1.0

1.1

—

Papulosquamous disorders

3.57

1.61

1.0

1.1

—

Obesity due to excess calories

2.86

1.50

1.2

1.0

—

Used for control exclusion in common control thyroid runs

2.31

1.49

1.0

1.2

—

Pain (limb, back, neck, head abdominally)

3.58

1.44

1.0

1.1

—

Necrosis of pulp, including avohilmo

2.47

1.43

1.0

—

Obesity

2.44

1.40

1.1

—

Care involving use of rehabilitation procedures

2.70

1.40

1.2

1.1

—

Obesity and other hyperalimentation

2.44

1.39

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.59

1.31

1.0

1.2

—

Visual disturbances

2.78

1.28

1.2

1.1

—

Hypertension, essential

2.61

1.27

1.0

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.60

1.19

1.2

1.1

—

Other and unspecified dermatitis

2.31

1.18

1.2

1.0

—

Acute appendicitis, no complications

2.29

1.17

1.0

—

Low back pain

2.49

1.16

1.0

1.1

—

Visual disturbances and blindness

2.50

1.15

1.2

1.1

—

All anxiety disorders

2.26

1.10

1.0

—

Periapical abscess

2.38

1.09

1.0

—

Other nutritional deficiencies

2.20

1.08

1.1

—

Artrosis, including avohilmo

2.25

1.08

1.0

1.1

—

Depression

2.07

1.07

1.0

1.1

—

Acute appendicitis

2.16

1.07

1.0

1.1

—

Dental pulpitis, including avohilmo

1.99

1.04

1.2

1.0

—

Anxiety disorders, excluding more controls

2.13

1.04

1.0

1.1

—

Injuries to the ankle and foot

2.06

1.02

1.1

1.0

—

Mood [affective] disorders

1.92

1.01

1.0

1.1

—

Mood disorders

1.92

1.01

1.0

1.1

—

Tramadol

2.00

0.97

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.97

0.90

1.0

1.1

—

Anxiety disorders

1.96

0.90

1.0

1.1

—

Malignant neoplasm of skin, including Hilmo

0.00

0.81

0.0

1.1

—

Hypertensive diseases (excluding secondary)

2.24

0.77

1.0

1.2

—

Hypertensive diseases

2.17

0.76

1.0

1.2

—

Hypertension

2.17

0.76

1.0

1.2

—

L04AX Other immunosuppressants

2.08

0.74

1.0

—

Infections of the skin and subcutaneous tissue

2.05

0.73

1.2

1.0

—

All chronic kidney diseases

1.99

0.72

1.4

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.98

0.72

1.0

—

Second line medication for Crohn's disease

1.85

0.68

1.0

1.1

—

Inguinal hernia

1.75

0.63

1.2

1.1

—

malignant neoplasm of male genital organs, including Hilmo

0.00

0.63

0.0

1.1

—

Basal cell carcinoma

0.00

0.61

0.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

0.61

0.0

1.1

—

Basal cell carcinoma, including Hilmo

0.00

0.61

0.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.00

0.61

0.0

1.1

—

Persons with potential health hazards related to communicable diseases

0.00

0.60

0.0

1.0

—

Keratitis

0.00

0.60

0.0

1.1

—

Malignant neoplasm of skin

0.00

0.60

0.0

1.1

—

Neoplasms

1.57

0.53

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.63

0.44

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

0.00

0.42

0.0

1.2

—

malignant neoplasm of male genital organs

0.00

0.42

0.0

1.1

—

Malignant neoplasm of prostate

0.00

0.42

0.0

1.1

—

Malignant neoplasm of prostate, including Hilmo

0.00

0.41

0.0

1.1

—

Oxycodone

0.00

0.41

0.0

1.1

—

Other disorders of veins

0.00

0.41

0.0

1.1

—

Embedded and impacted teeth

0.00

0.41

0.0

1.0

—

Fracture at wrist and hand level

0.00

0.40

0.0

1.1

—

Contact with and exposure to communicable diseases

0.00

0.40

0.0

1.0

—

Atopic dermatitis

1.47

0.40

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.00

0.40

0.0

1.1

—

Fracture of shoulder and upper arm

0.00

0.40

0.0

1.1

—

Caries of enamel

1.39

0.32

1.1

—

Injuries to the elbow and forearm

1.34

0.23

1.2

1.0

—

Antenatal screening

0.00

0.22

0.0

1.0

—

Supervision of normal pregnancy

0.00

0.22

0.0

1.0

—

Heart failure and bmi 25plus

0.00

0.22

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative

0.00

0.22

0.0

1.0

—

Malignant neoplasm of breast

0.00

0.22

0.0

1.0

—

Colorectal cancer

0.00

0.21

0.0

1.0

—

Conjunctivitis (acute, non atopic)

0.00

0.21

0.0

1.1

—

Disorders of refraction and accommodation

0.00

0.21

0.0

1.1

—

Intestinal stricture

0.00

0.21

0.0

1.1

—

Disturbances of skin sensation

0.00

0.21

0.0

1.1

—

Diaphragmatic hernia

0.00

0.21

0.0

1.1

—

Glaucoma suspect

0.00

0.21

0.0

1.1

—

Colorectal cancer, including Hilmo

0.00

0.21

0.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

0.00

0.21

0.0

1.1

—

Diseases of external ear

0.00

0.21

0.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.00

0.20

0.0

1.1

—

Falls/tendency to fall

1.17

0.18

1.0

1.1

—

Fall on same level

1.13

0.17

1.0

1.1

—

Hernia

1.07

0.09

1.2

1.1

—

Opioids

1.11

0.09

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

0.0

1.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.2

—

Supervision of high-risk pregnancy

0.00

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

0.0

1.0

—

Other disorders of breast

0.00

0.0

1.2

—

Codeine

1.00

0.00

1.0

1.1

—

Enthesopathies of lower limb, excluding foot

0.00

0.0

1.1

—

Malignant melanoma of skin, including Hilmo

0.00

0.0

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.0

—

Otitis externa

0.00

-0.00

0.0

1.1

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.0

—

Candidiasis, including avohilmo

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of colon

0.00

-0.00

0.0

1.0

—

Car occupant injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Deforming dorsopathies

0.00

-0.00

0.0

1.1

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Tooth eruption problems

0.00

-0.00

0.0

1.0

—

Acute renal failure

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast

0.00

-0.00

0.0

1.2

—

Other noninflammatory disorders of uterus, except cervix

0.00

-0.00

0.0

1.2

—

Medicines for HER+ breast cancer

0.00

-0.00

0.0

1.1

—

DVT of lower extremities

0.00

-0.00

0.0

1.0

—

Adverse effects, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other abnormal uterine and vaginal bleeding

0.00

-0.00

0.0

1.2

—

L02BG Aromatase inhibitors

0.00

-0.00

0.0

1.2

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.0

—

Premature rupture of membranes

0.00

-0.00

0.0

1.0

—

Poor fetal growth

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm

0.00

-0.00

0.0

1.1

—

Nasal polyp

0.00

-0.00

0.0

1.1

—

Diseases of salivary glands

0.00

-0.00

0.0

1.1

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Viral warts, including avohilmo

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.2

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Other gastritis (incl. Duodenitis)

0.00

-0.00

0.0

1.1

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign thyroid growths and nodules

0.00

-0.00

0.0

1.1

—

Nontoxic goitre/thyroid nodule

0.00

-0.00

0.0

1.2

—

Disorders of parathyroid gland

0.00

-0.00

0.0

1.2

—

Blepharochalasis

0.00

-0.00

0.0

1.1

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

-0.00

0.0

1.2

—

Follicular cysts of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

Corneal ulcer

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

1.1

—

Disorders of psychological development

0.00

-0.00

0.0

1.0

—

Use of pramipexole

0.00

-0.00

0.0

1.2

—

Hypertrophy of breast in women and men

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of rectum, including Hilmo

0.00

-0.00

0.0

1.0

—

Stomatitis and related lesions

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Other menopausal disorders

0.00

-0.00

0.0

1.2

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

Other and unspecified urticaria

0.00

-0.00

0.0

1.1

—

Postmenopausal atrophic vaginitis

0.00

-0.00

0.0

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.0

—

Long labour

0.00

-0.00

0.0

1.2

—

Maternal care for known or suspected fetal abnormality and damage

0.00

-0.00

0.0

1.0

—

Ectopic pregnancy

0.00

-0.00

0.0

1.2

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER-positive

0.00

-0.00

0.0

1.0

—

Preterm labour and delivery

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lymphocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS